000 | 01724 a2200469 4500 | ||
---|---|---|---|
005 | 20250513202117.0 | ||
264 | 0 | _c20000217 | |
008 | 200002s 0 0 eng d | ||
022 | _a0003-4975 | ||
024 | 7 |
_a10.1016/s0003-4975(99)01052-8 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVural, K M | |
245 | 0 | 0 |
_aEffects of mast cell membrane stabilizing agents in a rat lung ischemia-reperfusion model. _h[electronic resource] |
260 |
_bThe Annals of thoracic surgery _cJan 2000 |
||
300 |
_a228-32 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Asthmatic Agents _xtherapeutic use |
650 | 0 | 4 |
_aCell Membrane _xdrug effects |
650 | 0 | 4 |
_aCromolyn Sodium _xtherapeutic use |
650 | 0 | 4 |
_aCyclic GMP _xanalysis |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
650 | 0 | 4 |
_aHistamine H1 Antagonists _xtherapeutic use |
650 | 0 | 4 |
_aIntercellular Adhesion Molecule-1 _xanalysis |
650 | 0 | 4 |
_aIschemia _xmetabolism |
650 | 0 | 4 |
_aKetotifen _xtherapeutic use |
650 | 0 | 4 |
_aLung _xblood supply |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMast Cells _xdrug effects |
650 | 0 | 4 |
_aNitric Oxide Synthase _xanalysis |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReperfusion Injury _xmetabolism |
700 | 1 | _aLiao, H | |
700 | 1 | _aOz, M C | |
700 | 1 | _aPinsky, D J | |
773 | 0 |
_tThe Annals of thoracic surgery _gvol. 69 _gno. 1 _gp. 228-32 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0003-4975(99)01052-8 _zAvailable from publisher's website |
999 |
_c10609518 _d10609518 |